Mechanism of Action: Artemether and Lumenfantrine (AL) is an antimalarial, artemisin based combination. Artemether is an artemisin derivative. This metabolite undergoes cleavage of it’s endoperoxidase ring inside the erythrocytes. As the drug molecules come in contact with the harm, the Iron II oxide breaks the endoperoxidase ring. This produces free radicals that in turn damage susceptible proteins, resulting in the death of the parasite. Lumenfantrine which has a longer half life compared to artemether clears any residual parasites that remains after treatment.
Dose: Adult & Child over 12yrs, with body weight over 35kg, AL as fixed dose is given by mouth twice daily for 3 days, with the 2nd dose given 8hrs after the 1st dose.
5-14kg- 1 tablet twice daily; 15-24kg- 2 tablets twice daily; 25-34kg- 3tablets twice daily.
Drug Formulation: Tablet
Quantity Per Pack: 24 Tablets
Place Of Production: Swiss Pharma Nigeria Ltd
Marketing Company: SWIPHA
Nafdac No: A4-2180
Reviews
There are no reviews yet.